Highlights | News

Research Highlights

Filter By Keyword
Filter By Year
30.11.2020
Professor Nektarios Tavernarakis elected Fellow of the American Association for the Advancement of Science

Nektarios Tavernarakis, Chairman of the Board of Directors at the Foundation for Research and Technology Hellas (FORTH) and Professor at the Medical School of the University of Crete, was elected Fellow of the American Association for the Advancement of Science (AAAS). This significant distinction comes as recognition of the scientific quality and the highly competitive research conducted at FORTH and the University of Crete. According to the Constitution of the prestigious AAAS, Fellowship is bestowed to scientists who have scientifically or socially distinguished themselves by efforts on behalf of the advancement of science, or its applications. Nominations for AAAS Fellows are evaluated for election by the Council of the Association. Nektarios Tavernarakis was honored for his distinguished contributions to the fields of ageing, neuroscience, mitochondrial biology, cell death and neurodegeneration.

09.11.2020
Professor Nektarios Tavernarakis elected Vice President of the European Research Council

As announced today in Brussels, Nektarios Tavernarakis, Chairman of the Board of Directors at the Foundation for Research and Technology – Hellas (FORTH), and Professor at the Medical School of the University of Crete, was unanimously elected Vice President of the European Research Council (ERC).

23.10.2020
The medal Vilhelm Bjerknes 2021 is awarded to Prof. Spyros Pandis, a collaborating faculty member of the Institute of Chemical Engineering Sciences of FORTH

The European Geoscience Union (EGU) will award Prof. Spyros Pandis the medal Vilhelm Bjerknes for 2021. Prof. Pandis is a collaborating faculty member of FORTH/ICE-HT (Institute of Chemical Engineering Sciences) and professor at the Department of Chemical Engineering of the University of Patras. This medal is awarded for significant disciplinary contributions in the Earth, planetary and space sciences and the ceremony will be held during the EGU Annual Assembly, 25-30 April 2021.

16.09.2020
New Spin-off Company founded by FORTH for the production of reflection-free glass that improves the quality of consumer electronics displays

A new spin-off company under the name “Biomimetic” was created leveraging patented technology developed at the Institute of Electronic Structure and Laser (IESL, www.iesl.forth.gr) of the Foundation for Research and Technology-Hellas (www.forth.gr). The company was founded by the Research Director Dr. Emmanuel Stratakis, together with FORTH research personnel Dr. Evangelos Skoulas, Mr. Andreas Lemonis, Mr. Antonis Papadopoulos and Mr. Alexandros Mimidis, as co-founders. The company raised 900.000€ seed funding by Big Pi Ventures (https://bigpi.vc/), one of the funds of EquiFund supported by the European Investment Fund (EIF). It is the second spin-off company of IESL that is financed by Big Pi within the last six months.

14.09.2020
Novel method for COVID-19 diagnosis developed at FORTH receives funding for immediate market release

Biosensors lab of FORTH(http://biosensorslab.biology.uoc.gr/) has developed a novel molecular diagnostic method for the detection of nucleic acids at the point-of-care. The method exploits a newly designed portable 3D-printed device and a smartphone to perform isothermal amplification and real-time quantitative colorimetric detection of the target analyte. The simplicity of the methodology, rapid analysis time (<30 min) and affordable cost make it ideal for non-trained users at the point-of-need and in both the developed and resource limited countries. Clinical validation of the device with patients’ samples, for infectious diseases (COVID-19) and cancer-mutations (BRAF V600E) detection, demonstrated excellent performance compared to standard methods.

11.09.2020
FORTH collaborating researcher’s major contribution to an important scientific publication in a leading medical journal, about a targeted treatment for Tumor-Induced Osteomalacia (TIO).

Dr Georgios Z. Papadakis, collaborating researcher of the Institute of Computer Science (ICS) of the Foundation for Research and Technology – Hellas (FORTH), had a major contribution on a study published on September 10th 2020, in the New England Journal of Medicine (NEJM), in collaboration with scientists from the National Institutes of Health (NIH) in Bethesda, Maryland, USA.

18.08.2020
IMBB Researchers and Scientists from the University of Padova uncover a novel pathogenesis mechanism for Autosomal Dominant Optic Atrophy, an incurable, visual loss disorder.

The findings of the study, published yesterday in the premier international scientific journal Nature Communications, reveal a novel molecular mechanism underlying the detrimental effects of uncontrolled mitophagy on neuronal survival that contributes to the development and progression of Autosomal Dominant Optic Atrophy (ADOA).

30.07.2020
A European “Key Innovator” Distinction to an IESL project

The European project NANOPOLY (FETOPEN 2019 – 2022) that runs in the Institute of Electronic Structure and Laser (IESL) of the Foundation for Research and Technology Hellas (FORTH) has been awarded a “Key innovator” distinction by the European “Innovation Radar” https://www.innoradar.eu/resultbykeyword/nanopoly)

23.07.2020
Greece among the top European countries in Supercomputer technologies

Supercomputers and large Datacenters constitute basic infrastructure of strategic importance in modern society. Among the many sectors that they support, it suffices to mention the search for drugs against covid-19, and the fact that applications like gov.gr and global-scale teleconferencing, teleworking, and on-line education all run on large Datacenters. Recognizing the strategic importance of these High Performance Computing (HPC) technologies, the European Union has been funding related research, and has recently created the EuroHPC Joint Undertaking (JU) with a 1 billion Euro budget.

16.06.2020
Neuroimplants to treat spinal cord injuries

A pioneering research study by researchers at the Institute of Molecular Biology & Biotechnology of FORTH and the University of Crete suggests the development of neuroimplants for the regeneration of nerve tissue in cases of spinal cord injury. The materials and cells used are non-toxic for humans, and approved from FDA for their immediate translation in humans.

Total: 151 | Displaying 31 - 40

Page:123456789  | < Prev Next >